Addressing race in healthcare through the faith and through the law

The Christian Medical Association has tackled race issues in healthcare proactively, gathering members together for prayer and fasting, webinars, public policy statements, articles, discussions, video presentations and more while pledging to "continue seeking to oppose racism in healthcare and society and pursuing justice in access to healthcare and equitable outcomes."

The U.S. Department of Health and Human Services (HHS) Office of Civil Rights (OCR) is likewise tackling race issues in healthcare, by communicating and enforcing federal law. OCR recently issued the following (excerpted) bulletin of guidance "to ensure that recipients of federal financial assistance understand that they must comply with applicable federal civil rights laws and regulations that prohibit discrimination on the basis of race, color, and national origin in HHS-funded programs during COVID-19:

To help ensure Title VI [of the Civil Rights Act of 1964] compliance during the COVID-19 public health emergency, recipients of federal financial assistance, including state and local agencies, hospitals, and other health care providers, should:

·         Adopt policies to prevent and address harassment or other unlawful discrimination on the basis of race, color, or national origin.

·         Ensure – when site selection is determined by a recipient of federal financial assistance from HHS – that Community-Based Testing Sites and Alternate Care Sites are accessible to racial and ethnic minority populations.

·         Confirm that existing policies and procedures with respect to COVID-19 related services (including testing) do not exclude or otherwise deny persons on the basis of race, color, or national origin.

·         Ensure that individuals from racial and ethnic minority groups are not subjected to excessive wait times, rejected for hospital admissions, or denied access to intensive care units compared to similarly situated non-minority individuals.

·         Provide – if part of the program or services offered by the recipient – ambulance service, non-emergency medical transportation, and home health services to all neighborhoods within the recipient's service area, without regard to race, color, or national origin.

My friend and colleague, HHS OCR Director Roger Severino, observed, "HHS is committed to helping populations hardest hit by COVID-19, including African-American, Native American, and Hispanic communities. This guidance reminds providers that unlawful racial discrimination in healthcare will not be tolerated, especially during a pandemic."

Vice Admiral Jerome M. Adams, Surgeon General, MD, MPH added, "Minorities have long experienced disparities related to the medical and social determinants of health – all of the things that contribute to your health and wellbeing. The COVID-19 pandemic has magnified those disparities, but it has also given us the opportunity to acknowledge their existence and impact and deepen our resolve to address them."

As CMDA has demonstrated and encouraged, followers of Christ can use this unique moment in our nation's history to advance principles of the faith regarding race. We can continue to promote the revolutionary biblical truth that every human being--of all races, both genders and at every point along the continuum of life from fertilization to natural death--carry the very image of God and as such merit our deepest respect, protection and love.

Resources

·         Read the new HHS OCR Bulletin: Title VI Bulletin - PDF

·         Learn more about non-discrimination on the basis of race, color, national origin, sex, age, and disability; conscience and religious freedom; and health information privacy laws, or file a complaint with HHS OCR: www.hhs.gov/ocr.

CMA doctors denounce judge's injunction against FDA safety precautions on abortion pill as a "pyrrhic victory" for abortion advocates

July 20, 2020—Bristol, TN: Today the 18,000-member Christian Medical Association (CMA, www.cmda.org) denounced an injunction issued by a federal district court judge that bars the FDA from enforcing health and safety precautions on a chemical abortion pill during the pandemic.

Dr. Jeffrey Barrows, an Ob-Gyn and CMA's Senior Vice President for Bioethics and Public Policy, said, "The judge handed pro-abortion forces a pyrrhic victory at the cost of women’s health and lives. The reason the FDA placed a Risk Evaluation and Mitigation Strategy (REMS) on mifepristone is that since its approval, 24 women have died from various complications including infection and internal hemorrhage.

"Since mifepristone was approved in 2000, 97 women have been documented with a pregnancy outside the womb--a life-threatening situation. I know from personal experience that these abnormal pregnancies are difficult to diagnose and require in-person consultation and examination. Prescription through telemedicine will hamper the ability to diagnose these abnormal pregnancies."

A federal district court judge for the District of Maryland on July 13 issued a preliminary injunction blocking Food and Drug Administration (FDA) enforcement for the “Elements to Assure Safe Use” in the Risk Evaluation Mitigation Strategy (REMS) for the chemical abortion pill mifepristone. The injunction allows mifepristone to be dispensed after telemedicine consult by clinics, medical offices, and hospitals via mail or delivery service and applies until thirty days after the end of the COVID-19 public health emergency.  

This injunction comes after Rep. Bob Latta (R-OH) and Senator Cindy Hyde-Smith (R-MS) led 38 Senators and 121 House Members in a bicameral letter urging FDA Commissioner Stephen Hahn to enforce the REMS.

The letter noted, "Unfortunately, there are some who seek to exploit this time of crisis to push for the weakening or overturning of critical Risk Evaluation and Mitigation Strategy (REMS) associated with medication abortion drugs, which would put women at significant risk."

The Congressional letter also highlighted that "research proves that as many as five to seven percent of women who take abortion drugs will require follow-up surgery, and three percent could end up in the emergency room. Self-managed abortions from home are especially dangerous; in fact, half of abortion providers do not consider them safe."

The Members of Congress had urged Hahn "to continue to robustly enforce the REMS for medication abortion....”